STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Syndax Announces Participation at the 8th Annual Evercore Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)

Syndax (Nasdaq: SNDX) announced that CEO Michael A. Metzger will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Thursday, December 4, 2025 at 11:15 a.m. ET.

A live webcast will be available in the company’s Investor section at www.syndax.com, and a replay will be posted for a limited time.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Thursday, December 4, 2025, at 11:15 a.m. ET.

A live webcast of the fireside chat will be available in the Investor section of the Company's website at www.syndax.com, where a replay will also be available for a limited time.

About Syndax

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company's pipeline include Revuforj® (revumenib), an FDA-approved menin inhibitor, and Niktimvo™ (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit www.syndax.com/ or follow the Company on and LinkedIn.

Syndax Contacts
Sharon Klahre
Syndax Pharmaceuticals, Inc.
sklahre@syndax.com
Tel 781.684.9827

SNDX-G


FAQ

When will Syndax (SNDX) present at the Evercore Healthcare Conference?

Syndax CEO will appear in a fireside chat on December 4, 2025 at 11:15 a.m. ET.

How can investors watch Syndax (SNDX) at the Evercore Healthcare Conference?

A live webcast will be available in the Investor section of www.syndax.com.

Will Syndax (SNDX) provide a replay of the Evercore presentation?

Yes, a replay will be available on the company website for a limited time after the event.

Who from Syndax (SNDX) is speaking at the Evercore Healthcare Conference?

Michael A. Metzger, Chief Executive Officer, will participate in the fireside chat.

What topics will Syndax (SNDX) cover in the Evercore fireside chat on December 4, 2025?

The announcement lists the CEO participation and webcast timing; specific presentation topics were not provided.
Syndax Pharmaceuticals Inc

NASDAQ:SNDX

SNDX Rankings

SNDX Latest News

SNDX Latest SEC Filings

SNDX Stock Data

1.73B
85.79M
1.29%
120.98%
24.28%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK